David Lloyd

Title: David Lloyd - Innovator in Parathyroid Hormone Variants

Introduction

David Lloyd is a notable inventor based in Leland, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of parathyroid hormone variants. His work focuses on improving therapeutic options for conditions related to calcium levels in the body.

Latest Patents

David Lloyd holds a patent for parathyroid hormone variants. This invention relates to parathyroid hormone (PTH) variants and pharmaceutical compositions that include these variants. The invention aims to enhance serum half-life and peak-trough ratios of PTH compositions. Additionally, it provides methods for controlling serum calcium levels using these PTH variants. The invention also addresses treatments for hypoparathyroidism and hypocalcemia resulting from hypoparathyroidism.

Career Highlights

David Lloyd is associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in pharmaceutical innovation. His work has led to advancements in the treatment of calcium-related disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Some of David's coworkers include Clark Qun Pan and Angela Norton. Their collaboration contributes to the innovative environment at Takeda Pharmaceutical Company Limited.

Conclusion

David Lloyd's contributions to the field of parathyroid hormone variants highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for improved treatments for patients with calcium-related health issues.